Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ILF3 Protein, N-His

Catalog #:   YHG33301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q12906
Protein length: Tyr672-Tyr891
Overview

Catalog No.

YHG33301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Tyr672-Tyr891

Predicted molecular weight

24.49 kDa

Nature

Recombinant

Concentration

0.3 mg/ml by bradford before be lyophilizion

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q12906

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in TBS pH 8.0, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

It suggests that the concentration of the protein be redissolved at 0.3mg/ml with sterile water.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ILF3, MPHOSPH4, DRBP76, TCP80, DRBF, Translational control protein 80, M-phase phosphoprotein 4, Nuclear factor associated with dsRNA, NF90, NFAR, MPP4, NF-AT-90, Double-stranded RNA-binding protein 76, Interleukin enhancer-binding factor 3, Nuclear factor of activated T-cells 90 kDa

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ILF3 protein
References

ILF3 mediates lipid metabolism to promote pancreatic cancer development by regulating CPT1A-activated PPARa signaling pathway., PMID:40419169

Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of ILF3., PMID:40381229

Zinc finger protein 184 prevents α-synuclein preformed fibril-mediated neurodegeneration through the interleukin enhancer binding factor 3-microRNA-7 pathway., PMID:40333790

Exome Sequencing to Identify Novel Susceptibility Genes for Nonsyndromic Split-Hand/Ft Malformation: A Report From the National Birth Defects Prevention Study., PMID:40304391

The impact of an RNA-binding protein group on regulating the RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular carcinoma., PMID:40264052

Integrative structural analysis of NF45-NF90 heterodimers reveals architectural rearrangements and oligomerization on binding dsRNA., PMID:40156862

Simvastatin inhibits PD-L1 via ILF3 to induce ferroptosis in gastric cancer cells., PMID:40140647

Identification of antiviral RNAi regulators, ILF3/DHX9, recruit at ZIKV stem loop B to protect against ZIKV induced microcephaly., PMID:40011444

8q24 derived ZNF252P promotes tumorigenesis by driving phase separation to activate c-Myc mediated feedback loop., PMID:40011431

CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR-15b-5p and miR-7-1-3p processing in nasopharyngeal carcinoma., PMID:39964093

RNA binding protein ILF3 increases CEP55 mRNA stability to enhance malignant potential of breast cancer cells and suppress ferroptosis., PMID:39871389

The highly conserved PIWI-interacting RNA CRAPIR antagonizes PA2G4-mediated NF110-NF45 disassembly to promote heart regeneration in mice., PMID:39814981

ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target., PMID:39735599

Circular RNA circPHLPP2 promotes tumor growth and anti-PD-1 resistance through binding ILF3 to regulate IL36γ transcription in colorectal cancer., PMID:39695693

Characterising a Novel Therapeutic Target for Psoriasis, TYK2, Using Functional Genomics., PMID:39684939

ILF2 protein is a promising serum biomarker for early detection of gastric cancer., PMID:39587551

Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA‑binding proteins through negative pressure wound therapy., PMID:39301661

Macrophage ILF3 promotes abdominal aortic aneurysm by inducing inflammatory imbalance in male mice., PMID:39179537

LncRNA ILF3-AS1 mediates oxidative stress and inflammation through miR-504-3p/HMGB1 axis in a cellular model of temporal lobe epilepsy., PMID:39135276

Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms., PMID:39118300

Single-cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target., PMID:38943472

Lefamulin Overcomes Acquired Drug Resistance via Regulating Mitochondrial Homeostasis by Targeting ILF3 in Hepatocellular Carcinoma., PMID:38874478

Smooth muscle NF90 deficiency ameliorates diabetic atherosclerotic calcification in male mice via FBXW7-AGER1-AGEs axis., PMID:38862515

Hypoxia-responsive lncRNA MIR155HG promotes PD-L1 expression in hepatocellular carcinoma cells by enhancing HIF-1α mRNA stability., PMID:38850791

Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer., PMID:38622522

Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis., PMID:38583797

Study of prognostic splicing factors in cancer using machine learning approaches., PMID:38538560

Identification of G-quadruplex-interacting proteins in living cells using an artificial G4-targeting biotin ligase., PMID:38452210

Role of ATF3 triggering M2 macrophage polarization to protect against the inflammatory injury of sepsis through ILF3/NEAT1 axis., PMID:38395749

LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis., PMID:38238853

SOX2-OT Binds with ILF3 to Promote Head and Neck Cancer Progression by Modulating Crosstalk between STAT3 and TGF-β Signaling., PMID:38136312

Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy., PMID:38079530

ILF3 safeguards telomeres from aberrant homologous recombination as a telomeric R-loop reader., PMID:37991243

Methyl donor diet attenuates intimal hyperplasia after vascular injury in rats., PMID:37844765

LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2., PMID:37840133

Genome-wide identification and functional analysis of dysregulated alternative splicing profiles in sepsis., PMID:37749550

LncRNA PTTG3P promotes tumorigenesis and metastasis of NSCLC by binding with ILF3 to maintain mRNA stability and form a positive feedback loop with E2F1., PMID:37705754

Prognostic and immunological role of cancer-associated fibroblasts-derived exosomal protein in esophageal squamous cell carcinoma., PMID:37634448

The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma., PMID:37389416

PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration., PMID:37337223

Negative regulation of HBG1/2 expression through S6K by long noncoding RNA NR_120526., PMID:37305725

A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma., PMID:37301543

LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2., PMID:37298108

SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model., PMID:37159520

A network of DZF proteins controls alternative splicing regulation and fidelity., PMID:37144502

Astragaloside IV promotes keratinocyte proliferation and migration through upregulating lncRNA H19 recruited ILF3 to enhance the stability of CDK4 mRNA., PMID:37132584

Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC., PMID:37077914

NUSAP1 Binds ILF2 to Modulate R-Loop Accumulation and DNA Damage in Prostate Cancer., PMID:37047232

Genome-wide CRISPR screens identify ILF3 as a mediator of mTORC1-dependent amino acid sensing., PMID:37037994

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis., PMID:37008925

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ILF3 Protein, N-His [YHG33301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only